TNF and atrial fibrillation: Interestingly, one patient treated with a fully human monoclonal antibody tumor necrosis factor inhibitor (TNFi), adalimumab, used for rheumatoid arthritis showed a response after tamoxifen discontinuation, suggesting either a possible late tamoxifen effect or a role of immunomodulation in AF pathogenesis and treatment.